This page has beta status

CMST COST Action CM0803
Functional peptidomimetic foldamers: from unnatural amino acids to self-assembling nanomaterials

The main objective of the Action is to develop peptidomimetic foldamers into a technology platform in drug discovery and biomedical applications. The goal is to relay the ideas, pharmacophore models and requirements among the potential biomedical applications (e.g., inhibition of protein-protein interactions, self-assembling nanostructured drug delivery systems, functional biomimetic materials, etc.), to the laboratories involved in foldamer design and synthesis, and the researchers who are continuously extending the pool of homologated amino acidss. This parallel top-down and bottom-up information handling is expected to boost the application oriented foldamer research in Europe.

(Descriptions are provided by the Actions directly via e-COST.)

General Information*

Chair of the Action:

Prof Ferenc FÜLÖP (HU)

Vice Chair of the Action:

Prof David J AITKEN (FR)

Science officer of the Action:

Dr Lucia FORZI

Administrative officer of the Action:

Ms Svetlana VOINOVA


Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF


Download Poster as PDF


Action website:

* content provided by e-COST.
Data is synchronised once per night.


Last updated: 02 May 2011 top of page